Renishaw plc

Renishaw plc is a British precision engineering company founded in 1973 and headquartered at Wotton-under-Edge, Gloucestershire. Listed on the London Stock Exchange, it reported record revenue of GBP 713.0 million in fiscal 2025, with adjusted profit before tax of GBP 127.2 million, and employs 5,342 people.

Industry Positioning

Renishaw is the component supplier the metrology industry is built on. Its Manufacturing Technologies division, at GBP 671.5 million, is 94% of group revenue and covers CMM probe heads and five-axis systems such as REVO, machine-tool probes, laser interferometers and optical encoder scales. Competitors make complete measuring machines; Renishaw makes the parts that decide whether those machines hold tolerance — and sells them to the companies it competes against.

The company invented the touch-trigger probe in the 1970s, and the installed base of that invention remains the commercial foundation. Retrofit and calibration work across existing CMM fleets underpins a revenue stream that does not depend on new machine sales.

Competitive Advantages

Encoder and interferometer technology is the deepest moat. Semiconductor lithography stages require position feedback accurate to fractions of a micrometre with no drift over millions of cycles, and very few suppliers worldwide can deliver it. That capability gives Renishaw a position in semiconductor equipment manufacturing that is largely insulated from machine-tool cycles.

Concentration is the second advantage. Because 94% of revenue comes from measurement, engineering effort compounds in one discipline rather than dispersing across divisions — the opposite of the diversified conglomerates it supplies. The company also owns its critical manufacturing: precision probes, synthetic ruby styli, transmission systems and encoder scales are produced in-house in the United Kingdom, Ireland and India.

Challenges & Outlook

Market geography has shifted east. China is now the largest single market at GBP 186.5 million, roughly 26% of revenue, and Asia-Pacific contributes GBP 337.7 million, about 47%. That concentration exposes the group to Chinese industrial policy and to local competitors moving up the precision ladder.

Cyclicality is the second pressure. In June 2025 Renishaw launched a cost-reduction programme targeting GBP 20 million of annualised savings, recognising redundancy costs, exiting its neurological drug-delivery business and closing an Edinburgh research site. That divestment removed the medical diversification that had partly insulated the group from manufacturing downturns, leaving it more purely exposed to metrology demand — and, at GBP 713 million, still far smaller than Hexagon or ZEISS. Fiscal 2025 nonetheless delivered record revenue and higher adjusted profit. VerityRank Score of 87/100.

Global Footprint

Renishaw operates 66 key locations worldwide — thirty sales locations in Asia-Pacific, twenty-one in EMEA and seven in the Americas — while keeping the bulk of research and manufacturing in the United Kingdom, with additional major production sites in Ireland and India. That arrangement is deliberate: precision probe and encoder manufacture depends on tacit process knowledge held by the workforce, so the company concentrates capability rather than distributing it. Revenue distribution (APAC GBP 337.7m, EMEA GBP 207.8m, Americas GBP 167.5m in fiscal 2025) shows an Asia-weighted business anchored in European manufacturing.